HK$ 4.66
Key Takeaways
Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
Sisram Medical Ltd, an investment holding company, designs, develops, manufactures, and sells energy-based aesthetic medical, minimally invasive treatment systems, and non-energy based devices and cosmeceuticals in the Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. It offers products and treatments portfolio, including hair removal, skin rejuvenation, acne and acne scars, body...
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITDA, reasonably pr
Target Price
The average target price of 1696.HK is 6.8 and suggests 45% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
